Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Coherus BioSciences Inc (NASDAQ:CHRS)

29.39
Delayed Data
As of Aug 26
 +0.04 / +0.14%
Today’s Change
12.04
Today|||52-Week Range
31.84
+28.01%
Year-to-Date
Better Buy: Amgen Inc. vs. Biogen
Aug 17 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close29.35
Today’s open29.36
Day’s range28.79 - 30.00
Volume220,749
Average volume (3 months)404,081
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+43.52%
Earnings growth (this year)+0.22%
Earnings growth (next 5 years)--
Revenue growth (last year)-3.42%
P/E ratioNM
Price/Sales28.37
Price/Book--

Competitors

 Today’s
change
Today’s
% change
HALOHalozyme Therapeutic...+0.27+2.83%
FPRXFive Prime Therapeut...+0.93+2.13%
XLRNAcceleron Pharma Inc+0.56+1.89%
RLYPRelypsa Inc+0.01+0.03%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateDecember 12, 2016
EPS forecast (this quarter)-$1.55
Annual revenue (last year)$30.0M
Annual profit (last year)-$223.3M
Net profit margin-743.18%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Denny M. Lanfear
Chief Financial Officer
Jean-Frédéric Viret
Corporate headquarters
Redwood City, California

Forecasts

Partner Offers

Search for Jobs